271 related articles for article (PubMed ID: 11895912)
41. NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution.
de Aguiar Gonçalves BA; Vasconcelos GM; Thuler LC; Andrade C; Faro A; Pombo-de-Oliveira MS; ; Emerenciano M; de Camargo B; Bernstain L; Neves CC; Agareno JM; de Carvalho LM; Araújo FN; de Brito NP; Magalhães IQ; Cordoba JC; Pimenta F; Gadelha A; Cartaxo E; Basegio RM; Mnayarji A; Souza MS; Arencibia A; Melaragno R; Cóser VM; Lafayete TC; Koifman S
Cancer Causes Control; 2012 Nov; 23(11):1811-9. PubMed ID: 22976839
[TBL] [Abstract][Full Text] [Related]
42. [Genetic determinants of childhood leukemia].
Sinnett D; N'Diaye N; Labuda D; Krajinovic M
Bull Cancer; 2006 Sep; 93(9):857-65. PubMed ID: 16980228
[TBL] [Abstract][Full Text] [Related]
43. [Preliminary study on polymorphism of GSTM1, CYP2E1 and NQO1 genes and risk factors of children leukemia].
Wu YX; Gao YJ; Zhao JC; Jing XP; Xia ZL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):819. PubMed ID: 15555372
[No Abstract] [Full Text] [Related]
44. Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population.
Al-Dayel F; Al-Rasheed M; Ibrahim M; Bu R; Bavi P; Abubaker J; Al-Jomah N; Mohamed GH; Moorji A; Uddin S; Siraj AK; Al-Kuraya K
Leuk Lymphoma; 2008 Jan; 49(1):122-9. PubMed ID: 18203021
[TBL] [Abstract][Full Text] [Related]
45. The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia.
Barragan E; Collado M; Cervera J; Martin G; Bolufer P; Roman J; Sanz MA
Leuk Res; 2007 Jul; 31(7):947-53. PubMed ID: 17118447
[TBL] [Abstract][Full Text] [Related]
46. Metabolism of xenobiotics and chemical carcinogenesis.
Lang M; Pelkonen O
IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma.
Ashton LJ; Murray JE; Haber M; Marshall GM; Ashley DM; Norris MD
Pharmacogenet Genomics; 2007 Sep; 17(9):709-17. PubMed ID: 17700360
[TBL] [Abstract][Full Text] [Related]
48. Genetic susceptibility to childhood acute lymphoblastic leukemia.
Sinnett D; Krajinovic M; Labuda D
Leuk Lymphoma; 2000 Aug; 38(5-6):447-62. PubMed ID: 10953966
[TBL] [Abstract][Full Text] [Related]
49. Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferases (GSTs).
Brockstedt U; Krajinovic M; Richer C; Mathonnet G; Sinnett D; Pfau W; Labuda D
Mutat Res; 2002 Apr; 516(1-2):41-7. PubMed ID: 11943609
[TBL] [Abstract][Full Text] [Related]
50. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes in a Brazilian population.
Silveira Vda S; Canalle R; Scrideli CA; Queiroz RG; Tone LG
Biomarkers; 2009 Mar; 14(2):111-7. PubMed ID: 19330589
[TBL] [Abstract][Full Text] [Related]
51. The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group.
Stanulla M; Dynybil C; Bartels DB; Dördelmann M; Löning L; Claviez A; Schrappe M;
Haematologica; 2007 Nov; 92(11):1581-2. PubMed ID: 18024413
[TBL] [Abstract][Full Text] [Related]
52. Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms.
Infante-Rivard C; Labuda D; Krajinovic M; Sinnett D
Epidemiology; 1999 Sep; 10(5):481-7. PubMed ID: 10468419
[TBL] [Abstract][Full Text] [Related]
53. Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotype.
Pelkonen O; Raunio H; Rautio A; Lang M
IARC Sci Publ; 1999; (148):77-88. PubMed ID: 10493250
[TBL] [Abstract][Full Text] [Related]
54. Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. The International Pancreatic Disease Study Group.
Bartsch H; Malaveille C; Lowenfels AB; Maisonneuve P; Hautefeuille A; Boyle P
Eur J Cancer Prev; 1998 Jun; 7(3):215-23. PubMed ID: 9696930
[TBL] [Abstract][Full Text] [Related]
55. DNA repair gene polymorphism is associated with the genetic basis of atherosclerotic coronary artery disease.
Bazo AP; Salvadori D; Salvadori RA; Sodré LP; da Silva GN; de Camargo EA; Ribeiro LR; Salvadori DM
Cardiovasc Pathol; 2011; 20(1):e9-15. PubMed ID: 20093049
[TBL] [Abstract][Full Text] [Related]
56. Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia.
Krajinovic M; Sinnett H; Richer C; Labuda D; Sinnett D
Int J Cancer; 2002 Jan; 97(2):230-6. PubMed ID: 11774269
[TBL] [Abstract][Full Text] [Related]
57. Role of DNA mismatch repair genetic polymorphisms in the risk of childhood acute lymphoblastic leukaemia.
Mathonnet G; Krajinovic M; Labuda D; Sinnett D
Br J Haematol; 2003 Oct; 123(1):45-8. PubMed ID: 14510941
[TBL] [Abstract][Full Text] [Related]
58. Genetic predisposition and treatment-related leukemia.
Perentesis JP
Med Pediatr Oncol; 2001 May; 36(5):541-8. PubMed ID: 11340609
[TBL] [Abstract][Full Text] [Related]
59. Functional polymorphism of detoxification gene NQO1 predicts intensity of empirical treatment of childhood asthma.
Goodrich GG; Goodman PH; Budhecha SK; Pritsos CA
Mutat Res; 2009 Mar; 674(1-2):55-61. PubMed ID: 19027876
[TBL] [Abstract][Full Text] [Related]
60. Challenges identifying genetic determinants of pediatric cancers--the childhood leukemia experience.
Sinnett D; Labuda D; Krajinovic M
Fam Cancer; 2006; 5(1):35-47. PubMed ID: 16528607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
